We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'
Two pharmacists who sold ‘industrial’ quantities of Class C controlled drugs were yesterday sentenced to two years’ imprisonment each, suspended for 24 months, at Southwark Crown Court following an investigation by the Criminal Enforcement Unit of the Medicines and Healthcare...
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
How traditional herbal medicines and homeopathic medicines will be treated by the MHRA.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Kieron Banks (34) was sentenced today at the Nightingale Court in Wolverhampton for the illegal possession and intent to supply prescription-only medication valued at over £2m following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA).
This guidance sets out how the MHRA is handling centralised applications that were still pending on 1 January 2021.
Licences and authorisations to import genetic material, research and diagnostic samples, trade samples and display items, and some live animals and animal products.
Industry must notify the MHRA if they will not be using these flexibilities
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
People are urged to seek advice from healthcare professionals if they feel they have become dependent on or addicted to codeine linctus.
Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.
Check if someone selling medicines online in Northern Ireland is allowed to do so by the Medicines and Healthcare products Regulatory Agency (MHRA)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).